These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21314231)

  • 41. Pathogenesis and disease-modifying therapy in Alzheimer's disease: the flat line of progress.
    Castellani RJ; Perry G
    Arch Med Res; 2012 Nov; 43(8):694-8. PubMed ID: 23085451
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Research and development of anti-Alzheimer's drugs: an analysis based on technology flows measured by patent citations.
    Xu J; Kong X; Qiu L; Geng X; Hu Y; Wang Y
    Expert Opin Ther Pat; 2014 Jul; 24(7):791-800. PubMed ID: 24798577
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Environmental toxins and Alzheimer's disease progression.
    Vasefi M; Ghaboolian-Zare E; Abedelwahab H; Osu A
    Neurochem Int; 2020 Dec; 141():104852. PubMed ID: 33010393
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Revisit to Etiopathogenesis and Therapeutic Strategies in Alzheimer's Disease.
    Kumar M; Bansal N
    Curr Drug Targets; 2022; 23(5):486-512. PubMed ID: 34792002
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vitamin D in the development and progression of alzheimer's disease: implications for clinical management.
    Panza F; La Montagna M; Lampignano L; Zupo R; Bortone I; Castellana F; Sardone R; Borraccino L; Dibello V; Resta E; Altamura M; Daniele A; Lozupone M
    Expert Rev Neurother; 2021 Mar; 21(3):287-301. PubMed ID: 33406925
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The role of biological sciences in understanding the genesis and a new therapeutic approach to Alzheimer's disease].
    Tęgowska E; Wosińska A
    Postepy Hig Med Dosw (Online); 2011 Feb; 65():73-92. PubMed ID: 21357996
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The search for disease-modifying treatment for Alzheimer's disease.
    Aisen PS; Davis KL
    Neurology; 1997 May; 48(5 Suppl 6):S35-41. PubMed ID: 9153159
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of Alzheimer's disease: future directions.
    Wilcock GK; Harrold PL
    Acta Neurol Scand Suppl; 1996; 165():128-36. PubMed ID: 8741000
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of the Extracellular Matrix in Alzheimer's Disease.
    Sun Y; Xu S; Jiang M; Liu X; Yang L; Bai Z; Yang Q
    Front Aging Neurosci; 2021; 13():707466. PubMed ID: 34512308
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insulin Peptides as Mediators of the Impact of Life Style in Alzheimer's disease.
    Fernandez AM; Santi A; Torres Aleman I
    Brain Plast; 2018 Dec; 4(1):3-15. PubMed ID: 30564544
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Roles of cholesterol and lipids in the etiopathogenesis of Alzheimer's disease.
    Rojo L; Sjöberg MK; Hernández P; Zambrano C; Maccioni RB
    J Biomed Biotechnol; 2006; 2006(3):73976. PubMed ID: 17047312
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Angiotensins and Alzheimer's disease: a bench to bedside overview.
    Kehoe PG
    Alzheimers Res Ther; 2009 Jul; 1(1):3. PubMed ID: 19674436
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alzheimer's disease. Clues to the cause.
    Gorelick PB; Bózzola FG
    Postgrad Med; 1991 Mar; 89(4):231-2, 237-8, 240. PubMed ID: 2000357
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular details of aluminium-amyloid β peptide interaction by nuclear magnetic resonance.
    Petersingham G; Zaman MS; Johnson AJ; Reddy N; Torres AM; Wu MJ
    Biometals; 2022 Aug; 35(4):759-769. PubMed ID: 35639270
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Abundance of Nef and p-Tau217 in Brains of Individuals Diagnosed with HIV-Associated Neurocognitive Disorders Correlate with Disease Severance.
    Pushkarsky T; Ward A; Ivanov A; Lin X; Sviridov D; Nekhai S; Bukrinsky MI
    Mol Neurobiol; 2022 Feb; 59(2):1088-1097. PubMed ID: 34843091
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuroprotective Approach of Anti-Cancer Microtubule Stabilizers Against Tauopathy Associated Dementia: Current Status of Clinical and Preclinical Findings.
    Duggal P; Mehan S
    J Alzheimers Dis Rep; 2019 Jul; 3(1):179-218. PubMed ID: 31435618
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proniosomes derived niosomes: recent advancements in drug delivery and targeting.
    Khatoon M; Shah KU; Din FU; Shah SU; Rehman AU; Dilawar N; Khan AN
    Drug Deliv; 2017; 24(sup1):56-69. PubMed ID: 29130758
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epigenetic Regulatory Mechanisms Induced by Resveratrol.
    Fernandes GFS; Silva GDB; Pavan AR; Chiba DE; Chin CM; Dos Santos JL
    Nutrients; 2017 Nov; 9(11):. PubMed ID: 29104258
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Amyloid Beta-Mediated Hypomethylation of Heme Oxygenase 1 Correlates with Cognitive Impairment in Alzheimer's Disease.
    Sung HY; Choi BO; Jeong JH; Kong KA; Hwang J; Ahn JH
    PLoS One; 2016; 11(4):e0153156. PubMed ID: 27058954
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional and molecular neuroimaging of menopause and hormone replacement therapy.
    Comasco E; Frokjaer VG; Sundström-Poromaa I
    Front Neurosci; 2014; 8():388. PubMed ID: 25538545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.